Regenerative medicine: transdifferentiation in vivo
- PMID: 24343579
- PMCID: PMC3915906
- DOI: 10.1038/cr.2013.165
Regenerative medicine: transdifferentiation in vivo
Abstract
A major challenge in regenerative medicine is the generation of functionally effective target cells to replace or repair damaged tissues. Transdifferentiation in vivo is a novel strategy to achieve cell fate conversion within the native physiological niche; this technology may provide a time- and cost-effective alternative for applications in regenerative medicine and may also minimize the concerns associated with in vitro culture and cell transplantation.
References
-
- Takahashi K, Tanabe K, Ohnuki M, et al. Cell. 2007. pp. 861–872. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
